Literature DB >> 12665039

Principal component analysis as a method to facilitate fast detection of transient-evoked otoacoustic emissions.

Paolo Ravazzani1, Gabriella Tognola, Marta Parazzini, Ferdinando Grandori.   

Abstract

Transient-evoked otoacoustic emissions (TEOAE) are acoustic signals coming from the inner ear (outer hair cells of the cochlea) after acoustic stimulation by clicks. They can be used to investigate the status of the peripheral hearing system. Some of their potential applications (e.g., their use as a tool in newborn hearing screening programs) are deeply related to the duration of each recording session. This duration can be strongly reduced by applying a principal component analysis approach to a set of TEOAE recorded from the same ear at different stimulus levels averaging only a few sweeps (a maximum of 100 versus the classical 260). The PCA approach is shown to be able to enhance the signal-to-noise ratio and, in turn, to allow a correct detection of the responses. Results of the application of this approach in comparison with responses recorded from the same subjects with the classical technique will be shown.

Mesh:

Year:  2003        PMID: 12665039     DOI: 10.1109/TBME.2002.807645

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  3 in total

1.  Signal-to-noise ratio improvement of swept-tone-generated transient otoacoustic emissions.

Authors:  Christopher L Bennett; Todor Mihajloski; Özcan Özdamar
Journal:  Med Biol Eng Comput       Date:  2016-04-22       Impact factor: 2.602

2.  Post-processing analysis of transient-evoked otoacoustic emissions to detect 4 kHz-notch hearing impairment--a pilot study.

Authors:  Giovanna Zimatore; Anna Rita Fetoni; Gaetano Paludetti; Marta Cavagnaro; Maria Vittoria Podda; Diana Troiani
Journal:  Med Sci Monit       Date:  2011-06

3.  Assessment of potential effects of the electromagnetic fields of mobile phones on hearing.

Authors:  Ingrida Uloziene; Virgilijus Uloza; Egle Gradauskiene; Viktoras Saferis
Journal:  BMC Public Health       Date:  2005-04-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.